Literature DB >> 14576517

Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery.

Haim D Danenberg1, Ilia Fishbein, Hila Epstein, Johannes Waltenberger, Evgeny Moerman, Jukka Mönkkönen, Jianchuan Gao, Irith Gathi, Reuven Reichi, Gershon Golomb.   

Abstract

OBJECTIVES: Macrophage depletion by liposomal clodronate inhibits neointimal formation after balloon-injury. The present study examined bisphosphonates (BPs) potency-effect relationship and the role of systemic versus local monocytes in vascular repair. METHODS AND
RESULTS: Liposomal preparations of clodronate, pamidronate, alendronate, and ISA-13-1 inhibited RAW-264 macrophages growth in a dose-response manner. Administration to balloon-injured rats suppressed neointimal growth. Neointima to media ratio (N/M) at 14 days was reduced from 1.35 +/- 0.22 (control) to 0.4 +/- 0.1 and 0.9 +/- 0.17 by liposomal alendronate (1.5 mg/kg, i.v.) and liposomal ISA-13-1 (15 mg/kg), respectively (n = 8-10, P < 0.05). Suppression of neointimal formation was preserved at 30 days. Subcutaneous administration of liposomal BP (LBP) was also effective in suppressing neointimal formation, while short local intraluminal application had no effect. Immunostaining for ED-1 and ED-2 revealed no resident macrophages in the arterial wall, and reduced macrophage infiltration in LBP-treated animals. Arterial PDGF-B chain and PDGF-beta receptor activation were reduced in LBP-treated animals and up-regulation of the PDGF receptor was noted.
CONCLUSIONS: Systemic transient inactivation of monocytes and macrophages by LBPs reduced macrophage infiltration and neointimal formation in the rat carotid injury model. The findings demonstrate a BP potency-effect relationship, and highlight the role of circulating monocytes in vascular injury and repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576517     DOI: 10.1097/00005344-200311000-00014

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  23 in total

1.  Bisphosphonate-mediated gene vector delivery from the metal surfaces of stents.

Authors:  Ilia Fishbein; Ivan S Alferiev; Origene Nyanguile; Richard Gaster; John M Vohs; Gordon S Wong; Howard Felderman; I-Wei Chen; Hoon Choi; Robert L Wilensky; Robert J Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-21       Impact factor: 11.205

2.  Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge.

Authors:  H Epstein; E Grad; M Golomb; N Koroukhov; E R Edelman; G Golomb; H D Danenberg
Journal:  Atherosclerosis       Date:  2007-12-11       Impact factor: 5.162

3.  Enhanced biocompatibility of CD47-functionalized vascular stents.

Authors:  Joshua B Slee; Ivan S Alferiev; Chandrasekaran Nagaswami; John W Weisel; Robert J Levy; Ilia Fishbein; Stanley J Stachelek
Journal:  Biomaterials       Date:  2016-02-08       Impact factor: 12.479

4.  Technical advance: liposomal alendronate depletes monocytes and macrophages in the nonhuman primate model of human disease.

Authors:  Benjamin J Burwitz; Jason S Reed; Katherine B Hammond; Merete A Ohme; Shannon L Planer; Alfred W Legasse; Adam J Ericsen; Yoram Richter; Gershon Golomb; Jonah B Sacha
Journal:  J Leukoc Biol       Date:  2014-05-13       Impact factor: 4.962

5.  Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling.

Authors:  Luis Rodriguez-Menocal; Mohd Hafeez Faridi; Laisel Martinez; Lina A Shehadeh; Juan C Duque; Yuntao Wei; Annia Mesa; Angela Pena; Vineet Gupta; Si M Pham; Roberto I Vazquez-Padron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

6.  Liposomal simvastatin attenuates neointimal hyperplasia in rats.

Authors:  Eyal Afergan; Meital Ben David; Hila Epstein; Nickolay Koroukhov; Dalia Gilhar; Keren Rohekar; Haim D Danenberg; Gershon Golomb
Journal:  AAPS J       Date:  2010-02-09       Impact factor: 4.009

7.  Vascular smooth muscle cell-derived transforming growth factor-β promotes maturation of activated, neointima lesion-like macrophages.

Authors:  Allison Ostriker; Henrick N Horita; Joanna Poczobutt; Mary C M Weiser-Evans; Raphael A Nemenoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

8.  Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.

Authors:  Brian K Stansfield; Waylan K Bessler; Raghuveer Mali; Julie A Mund; Brandon D Downing; Reuben Kapur; David A Ingram
Journal:  Am J Pathol       Date:  2013-11-07       Impact factor: 4.307

9.  OutFOXing myeloid cells in atherosclerosis with FoxOs.

Authors:  Mark W Feinberg
Journal:  Circ Res       Date:  2013-03-29       Impact factor: 17.367

10.  Targeted anti-inflammatory systemic therapy for restenosis: the Biorest Liposomal Alendronate with Stenting sTudy (BLAST)-a double blind, randomized clinical trial.

Authors:  Shmuel Banai; Ariel Finkelstein; Yaron Almagor; Abid Assali; Yonathan Hasin; Uri Rosenschein; Patricia Apruzzese; Alexandra J Lansky; Teruyoshi Kume; Elazer R Edelman
Journal:  Am Heart J       Date:  2012-12-11       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.